Page 35 - CJO_DIABETES_FRENCH_W17
P. 35

SOINS AUX PATIENTS



                         2015;31(6):1481-4. doi:10.12669/pjms.316.8204.  2005;19(1):45-51.
                      172. Giusti C. Transient hyperopic refractive changes in newly diag-  197.  Yildirim M, Kilic D, Dursun M, Dursun B. Diabetic papillopathy
                         nosed juvenile diabetes. Swiss Med Weekly 2003;133:200–20.  treated with intravitreal ranibizumab. Int Med Case Rep J 2017; 10,
                      173. Manaviat M, Rashidi M, Afkhami-Ardekani M, Shoja M. Prevalence   99-103.
                         of dry eye syndrome and diabetic retinopathy in type 2 diabetic   198. Kim M, Lee J, Lee S. Diabetic papillopathy with macular edema
                         patients. BMC Ophthalmol 2008;8:10. doi 10.1186/1471-2415-8-10  treated with intravitreal ranibizumab. Clin Ophthalmol 2013; 7:2257-
                      174. Kaiserman I, Kaiserman N, Nakar S, Vinker S. Dry eye in diabetic   60.
                         patients. Am J Ophthalmol 2005;139, 498-503.  199. Jacobson D, Vierkant R, Belongia E. A nonarteritic anterior
                      175. Canadian Association of Optometrists. Canadian Dry Eye Consen-  ischemic optic neuropathy. A case-control study of potential
                         sus Panel. 2014. National Dry Eye Disease Guidelines for Canadian   risk factors. Arch Ophthalmol 1997;115, 1403-7. doi:10.1001/ar-
                         Optometrists. Canadian Journal of Optometry Special Supplement   chopht.1997.01100160573008
                         76(1). Accessed online March 8, 2017 at: https://opto.ca/sites/de-  200. Atkins E, Bruce B, Newman N, Biousse V. Treatment of nonarteritic
                         fault/files/resources/documents/cjo_dry_eye_supplement_2014.pdf  anterior ischemic optic neuropathy. Surv Ophthalmol 2010;55:47-63.
                      176. Georgakopoulos CD, Makri OE, Pagoulatos D, et al. Effect of   201. Terelak-Borys B, Skonieczna K, Grabska-Liberek I. Ocular ischemic
                         omega-3 fatty acids dietary supplementation on ocular surface and   syndrome – a systematic review. Med Sci Monit 2012;18(8): RA138-
                         tear film in diabetic patients with dry eye. J Am Coll Nutr 2016;1-6.   RA144.
                         Doi:10.1080/07315724.2016.1170643         202. Watanabe K, Hagura R, Akanuma Y, et al. Characteristics of cranial
                      177.  Sacchetti M, Lambiase A. Diagnosis and management of neuro-  nerve palsies in diabetic patients. Diabetes Res Clin Pract 1990;10:
                         trophic keratitis. Clin Ophthalmol 2014;8:571-9.  19-27.
                      178. O’Donnell C, Efron N. Diabetes and contact lens wear. Clin Exp   203. Tamhankar MA, Biousse V, Ying GS, et al. Isolated third, fourth, and
                         Optom 2012;95, 328-37.                      sixth cranial nerve palsies from presumed microvascular versus
                      179.  Chew EY, Benson WE, Remaley NA, et al. Results after lens extrac-  other causes: A prospective study. Ophthalmology 2013;120:2264-9.
                         tion in patients with diabetic retinopathy. Arch Ophthalmol 1999;117,  204. Trigler L, Siatkowski RM, Oster AS, et al. Retinopathy in patients
                         1600. doi:10.1001/archopht.117.12.1600      with diabetic ophthalmoplegia. Ophthalmology 2003;110:145-50.
                      180. Krepler K, Biowski R, Schrey S, Jandrasits K, Wedrich A. Cataract   205. Galtrey C, Schon F, Nitkunan A. Microvascular non-arteritic ocular
                         surgery in patients with diabetic retinopathy: Visual outcome, pro-  motor nerve palsies - What we know and how should we treat?
                         gression of diabetic retinopathy, and incidence of diabetic macular   Neuro-Ophthalmology 2014;39:1-11. http://dx.doi.org/10.3109/016581
                         oedema. Graefe’s Arch Clin Exp Ophthalmol 2002;240:735-8. doi:   07.2014.963252
                         10.1007/s00417-002-0530-7
                      181.  Mozaffarieh M, Heinzl H, Sacu S, Wedrich A. Clinical outcomes of
                         phacoemulsification cataract surgery in diabetes patients: Visual
                         function (VF-14), visual acuity and patient satisfaction. Acta Oph-
                         thalmol Scand 2005;83, 176-83.
                      182. Kim S, Equi R, Bressler N. Analysis of macular edema after cataract
                         surgery in patients with diabetes using optical coherence tomogra-
                         phy. Ophthalmology 2007;114, 881-9.
                      183. Lanzagorta-Aresti A, Palacios-Pozo E, Menezo Rozalen JL, Navea-
                         Tejerina A. Prevention of vision loss after cataract surgery in dia-
                         betic macular edema with intravitreal bevacizumab: A pilot study.
                         Retina 2009;29(4):530-5.  doi: 10.1097/IAE.0b013e31819c6302
                      184. Mittra R, Borrillo J, Dev S, Mieler W, Koenig S. Retinopathy pro-
                         gression and visual outcomes after phacoemulsification in patients
                         with diabetes mellitus. Arch Ophthalmol 2000;118, 912-917. doi:10-
                         1001/pubs.Ophthalmol.-ISSN-0003-9950-118-7-ecs90087
                      185. Ostri C, Lund-Andersen H, Sander B, Cour M. Phacoemulsifica-
                         tion cataract surgery in a large cohort of diabetes patients: Visual
                         acuity outcomes and prognostic factors. J Cataract Refract Surg
                         2011;37(11)2006-12.
                      186. Skarbez K, Priestly Y, Hoepf M, Koevary S. Comprehensive review
                         of the effects of diabetes on ocular health. Expert Rev Ophthalmol
                         2010;5, 557-77.
                      187.  Yoshida M, Kimura H, Kyuk K, Ito M. Combined effect of vitamin E
                         and insulin on cataracts of diabetic rats fed a high cholesterol diet.
                         Biol Pharm Bull 2004 Mar;27(3):338-44.
                      188. Menchini U, Cappelli S, Virgili G. Cataract surgery and diabetic
                         retinopathy. Semin Ophthalmol 2003;18(3):103–8.
                      189. Barkana Y, Belkin M. Selective laser trabeculoplasty. Surv Ophthal-
                         mol 2007;52:634-54.
                      190. Koucheki B, Hashemi H. Selective laser trabeculoplasty in the treat-
                         ment of open-angle glaucoma. J Glaucoma 2012 Jan;21(1):65-70.
                         doi:10.1097/IJG.0b013e3182027596. PubMed PMID: 21278588.
                      191.  Davidorf FH, Mouser JG, Derick RJ. Rapid improvement of rubeo-
                         sis iridis from a single bevacizumab (Avastin) injection. Retina 2006
                         Mar;26(3):354-6.
                      192. Olmos LC, Sayed MS, Moraczewski AL, et al. Long-term outcomes
                         of neovascular glaucoma treated with and without intravitreal
                         bevacizumab. Eye 2016;30:463-72.
                      193. Rodrigues G, Abe RY, Zangalli C, et al. Neovascular glaucoma: A
                         review. Int J Retina Vitr 2016;2, 26.
                      194. Sayin N, Kara N, Pekel G. Ocular complications of diabetes mellitus.
                         World J Diabetes 2015;6(1):92-108.
                      195. Bayraktar Z, Alacali N, Bayraktar S. Diabetic papillopathy in type 2
                         diabetic patients. Retina 2002; 22(6):752-8.
                      196. Mansour A, El-Dairi M, Shehab M, Shanih H, Shaaban J, Anto-
                         nios S. Periocular corticosteroids in diabetic papillopathy. Eye



                      CANADIAN JOURNAL of OPTOMETRY    |    REVUE CANADIENNE D’OPTOMÉTRIE    VOL. 79  SUPPLEMENT 2, 2017  35




 36908_CJO_DIABETES   November 15, 2017 7:34 AM  APPROVAL: ___________________ DATE: ___________________
   30   31   32   33   34   35   36